001 Limited, an independent commercial energy and utility specialists, have recently joined One Nucleus and are excited to start connecting with fellow members from the Life Science industry.
Since 2001, 001 Limited has been using its expertise and experience of the energy market to help businesses across all industries to source sustainable solutions, secure competitive utility contracts and recover savings through conducting historic audits.
At this difficult economic time for businesses across the UK and the growing global climate crisis; 001 Limited is ready to help businesses with their…
COVID-19 swept the globe during 2020 leading to significant morbidity and mortality, impacting all aspects of life, including health and social care provision. This report, published today, demonstrates how people living with rare conditions were disproportionately affected.
In early 2020 a cross-sector group of concerned advocates came together to take Action for Rare Disease Empowerment (ARDEnt). They aimed to shed light on the unseen impact of the pandemic on people living with rare conditions to protect the precious existing services and build on any opportunities uncovered.
Information…
AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.Critical to enable meaningful comparisons between research studies and clinical trials, these well-characterized reference standards are extensively quality analyzed with molecular based assays and transmission electron microscope.Gene therapy researchers have long expressed the importance of well characterized AAV reference materials. Recombinant adeno-associated virus (rAAV) is a widely used gene delivery tool for research and clinical applications. Following…
"The acquisition of FGL enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers," states Jim Ellard, CEO of New England Biolabs. "It also further solidifies our ability to service customers in the molecular diagnostics space."
Martin Lee, Co-founder CEO of Fluorogenics, Ltd., states, "We are delighted to become part of an organization with which we share ideals, innovation and technical excellence, a passion to make a difference through the delivery of scientific solutions that…
Building a robust global patent portfolio for its ArestatTM platform
Cambridge, UK., 13 May 2021: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the grant by the United States Patent and Trademark Office of U.S. Utility Patent No. 10,925,965 B2, a patent that contributes to the Company’s global patent portfolio underpinning its ArestatTM technology platform. This US patent claims proprietary formulation technology aimed at enabling stabilised multi-dose protein products that are desirable in the…
Cambridge, UK: 12 May 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses throughout their life cycle as they translate great science into better patient outcomes. This includes facilitating connections between companies and expert services that enable members to operate safely, efficiently and with savings against key purchased items. The Group Purchasing Scheme saves members over £3M per annum via negotiated Preferred Supplier Agreements. Circular1 Health, a leading provider of Covid-19 testing to…
Cambridge, 12th May 2021: The Babraham Research Campus’ vision is to be one of the best places in the world for discovery bioscience research and innovation; a leading sustainable ecosystem to start, nurture, scale and grow bioscience business.
Already one of the UK’s leading locations to support world leading discovery research and early-stage bioscience enterprise, the Campus partners (The Babraham Institute, the Biotechnology and Biological Sciences Research Council, and Babraham Bioscience Technologies Ltd) have recently undertaken a strategic review of the Campus and the opportunity for…
Cambridge, UK: 11 May 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses throughout their life cycle as they translate great science into better patient outcomes. This includes facilitating connections between companies and expert development partners. tranScrip, a leading provider of specialist services to support Pharma and biotech companies on product development and life cycle management has become the latest company to join the One Nucleus Partner Programme. The programme is tailor-made to meet…
NOTTINGHAM, UK – 6 May, 2021 – Life Science Newswire – Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States. Dr. Lustig will play a crucial role in the company’s US expansion, following the opening of Sygnature’s second US office at Oyster Point, South San Francisco in April.A significant part of Sygnature’s customer base is already located in North America, ranging from major pharma through to small seed-funded biotechs, based all across the US and over the border…
Cambridge 10th May 2021: Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.The five-month programme, created out of a desire to support and nurture early-stage life science ventures attempting to navigate this fast-moving sector, offers up to five innovative entrepreneurs the opportunity to experience life as part of one of the most successful locations for life science start-ups in Europe.The programme, starting…